Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

LIGHT (TNFSF14) is a member of the TNF superfamily and is known to substitute for RANKL to induce osteoclast differentiation. LIGHT binds HVEM and LTβR, but it is not known whether these receptors play a role in osteoclast formation or whether LIGHT acts via RANKL signalling pathways. We found that both RANKL and LIGHT strongly induced phosphorylation of Akt and NFκB but not JNK in mouse osteoclast precursor cells. The addition of an Akt inhibitor showed decreased osteoclast differentiation and resorption mediated by both RANKL and LIGHT. RT-PCR and FACS analysis showed that CD14(+) human osteoclast precursors expressed HVEM and LTβR; expression levels of HVEM increased in the course of osteoclastogenesis and a decrease in LIGHT expression was associated with an increase in HVEM suggesting that there is a feedback loop related to this receptor. Our findings show that LIGHT is not inhibited by the soluble RANKL receptor OPG and that LIGHT is a potent osteoclastogenesis factor that activates the Akt, NFκB and JNK pathways.

Original publication




Journal article


Exp mol pathol

Publication Date





380 - 385


Cell Differentiation, Cells, Cultured, Humans, JNK Mitogen-Activated Protein Kinases, Leukocytes, Mononuclear, Lipopolysaccharide Receptors, Lymphotoxin beta Receptor, NF-kappa B, Osteoclasts, Osteoprotegerin, Proto-Oncogene Proteins c-akt, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B, Receptors, Tumor Necrosis Factor, Member 14, Signal Transduction, Stem Cells, Tumor Necrosis Factor Ligand Superfamily Member 14